Drugs

Scientists have developed a near infrared technology to non-invasively detect common pregnancy complications. The rate of overall pregnancy and childbirth complications in adult women in the US rose between 2014 and 2018 (1). This rise may be explained by the increase in women with pre-existing conditions before pregnancy and advanced maternal age (6). The most
0 Comments
Polyhydroxy acids, also known as PHAs, are a type of ingredient that is sometimes used in skincare.  What are PHAs in skincare, how do they work, and what are their potential benefits and side effects? What are PHAs in skincare? PHAs are small molecules with a specific structure and acidic pH, and they are a
0 Comments
Treatment for Molluscum Contagiosum Verrica Pharmaceuticals Announces Extension of FDA Review Period of its NDA for VP-102 for the Treatment of Molluscum Contagiosum WEST CHESTER, PA – May 28, 2021 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the
0 Comments
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses, including complete remissions, shown in patients with or without prior treatment Full approval supported by robust efficacy and safety data from two clinical trials — CAMBRIDGE, Mass., June 16, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that
0 Comments
palovarotene Treatment for Fibrodysplasia Ossificans Progressiva Ipsen Confirms U.S. FDA Accepts New Drug Application for Palovarotene as the First Potential Treatment Worldwide for Fibrodysplasia Ossificans Progressiva (FOP) PARIS, FRANCE, 28 May 2021 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that its New Drug Application (NDA) for palovarotene, an oral, investigational, selective RARγ agonist for the
0 Comments
FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use WHIPPANY, N.J.–(BUSINESS WIRE) June 17, 2021– Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC) product for the temporary relief of nasal congestion, runny nose, sneezing and itchy nose due to hay
0 Comments
A recent study suggests that smartwatches may have use in controlling insulin production through light-emitting diodes. Smartwatches use light-emitting diodes (LEDs) to monitor a range of physical health parameters, including heart rate, heart-rate variability, electrocardiograms, blood pressure, and sleep. Cells can be induced with continuous or pulsed green light. The green light emitted penetrates the
0 Comments
plinabulin Treatment for Neutropenia Associated with Chemotherapy BeyondSpring Announces U.S. FDA Acceptance And Priority Review Of New Drug Application For Plinabulin And G-CSF Combination For The Prevention Of Chemotherapy-Induced Neutropenia (CIN) NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer
0 Comments
Treatment for Opioid Overdose Adamis Provides Update on Zimhi SAN DIEGO, June 09, 2021 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s resubmitted New Drug Application (NDA) for ZIMHI™, which is its higher naloxone injection product candidate for the treatment of opioid overdose. Adamis received
0 Comments
FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia. “We are
0 Comments
Tazarotene is a relatively new prescription retinoid, and it is used to treat acne vulgaris, psoriasis, and other skin concerns.  How does tazarotene work, what is it used for, and what are the potential benefits and side effects? What is tazarotene? Tazarotene, also known as Tazorac, is a prescription topical cream that comes in 0.05%
0 Comments
ruxolitinib Treatment for Atopic Dermatitis, Vitiligo Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis WILMINGTON, Del.–(BUSINESS WIRE) June 11, 2021 — Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New
0 Comments
BOSTON–(BUSINESS WIRE)–Jun. 7, 2021– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of Ultomiris (ravulizumab-cwvz) to include children (one month of age and older) and adolescents with paroxysmal nocturnal hemoglobinuria (PNH). Ultomiris, a long-acting C5 inhibitor that offers immediate, complete and sustained complement inhibition, is now the first and only
0 Comments
FOSTER CITY, Calif.–(BUSINESS WIRE)–Jun. 10, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for the treatment of chronic hepatitis C virus (HCV) to now include children as young as 3 years of age, regardless of HCV
0 Comments
June 11, 2021 Audience:  Patient, Health Professional, Pharmacy  Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. The 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg have been found to contain levels of Nitrosodimethylamine (NDMA) impurities above acceptable daily limits.
0 Comments
BOSTON, June 01, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s
0 Comments
EAST HANOVER, N.J., June 1, 2021 /PRNewswire/ — Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of moderate to severe plaque psoriasis in pediatric patients six years and older who are candidates for systemic therapy or phototherapy1. This is the
0 Comments
Alpha-hydroxy acids are chemical compounds that are sometimes added to skincare products and in-office facial treatments.  What are alpha-hydroxy acids, what do they do, and what are their associated benefits and side effects? What are alpha-hydroxy acids? Alpha-hydroxy acids (AHAs) are molecules that have a relatively acidic pH and a specific chemical structure.  They are
0 Comments
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older First approval of a conjugate vaccine that helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia,1,2,3,4,5,6,7 including seven responsible for 40% of pneumococcal disease cases and deaths in the U.S. Helps protect against more serotypes
0 Comments
Does a positive diagnosis of COVID-19 increase the risk of heart attacks for those with pre-existing atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH)? It has been shown that higher rates of COVID-19 deaths can be associated with hypertension, heart failure, and cardiovascular disease. However, there were fewer patients reporting acute myocardial infarction (AMI), or
0 Comments
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a
0 Comments
Canadian researchers have proposed a method to detect COVID-19 infection rates in wastewater through sewer sensors. The COVID-19 pandemic has presented a challenge to researchers because some of the spread of the virus has been from people that show no symptoms of the virus (1). Known as asymptomatic carriers, it is unknown how many cases
0 Comments
FDA Approves Ryplazim (plasminogen, human-tvmh) for the Treatment of Plasminogen Deficiency Type 1 LAVAL, QC and CAMBRIDGE, England, June 4, 2021 /CNW Telbec/ – Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”) announced today that the U.S. Food & Drug Administration (FDA) has approved Ryplazim (plasminogen, human-tvmh) (“Ryplazim”) for the treatment of patients
0 Comments
A recent study examined whether the quality of a mother’s relationship with their infant will be affected by a history of depression. Psychologists have long been interested in the importance of a mother’s relationship with her child, and in particular, how depression in mothers may affect that relationship. Many studies have examined the effects of
0 Comments
FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Aduhelm™ (aducanumab-avwa) as the first and only Alzheimer’s
0 Comments